Q) Choledochal cyst III, treatment (MCH GI 2019)
A) Partial hepatic resection
B) Choledochojejunostomy
C) Transduodenal excision
D) Endoscopic drainage
Q) Choledochal cyst III, treatment (MCH GI 2019)
A) Partial hepatic resection
B) Choledochojejunostomy
C) Transduodenal excision
D) Endoscopic drainage
Q ) which is one of the criteria for diagnosis of gastric lymphadenopathy
a. mesenteric lymphoadenopathy
b. hepatic involvement
c. general lymph adenopathy
d . blood count within normal limt
Ans d
Dawson criteria
(1) absence of peripheral lymphadenopathy at the time of presentation;
(2) lack of enlarged mediastinal lymph nodes;
(3) normal total and differential white blood cell count
(4) predominance of bowel lesion at the time of laparotomy with only lymph nodes obviously affected in the immediate vicinity; and
(5) no lymphomatous involvement of liver and spleen
Q ) In Anal Carcinoma involvement of external iliac group of lymph nodes
a. Stage II
b. Stage III a
c. Stage III b
d) M1
Q) Optimal duration of tamoxifen in premenstrual women
a. 5 yrs
b. 10 yrs
c 3
d 15
Q About oncotype Dx Score
a) 21 gene recurrence score
b) Adding size improves score
c) Poor response to chemo with increasing score
d)
Q) All of the following are used for Nutritional Assessment except
a) Albumin
b) Prealbumin
c) Transferrin
d) PT/INR